Trials / Recruiting
RecruitingNCT06036563
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
A Multicenter Prospective Diagnostic Test: Screening and Differentiating Common Cancers (Cancers of Lung, Stomach, Colorectum, Esophagus, Liver, Breast and Pancreas) Based on Peripheral Blood Cell-Free DNA Sequencing
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,200 (estimated)
- Sponsor
- Air Force Military Medical University, China · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to screen and differentiate common cancers in participants with or without suspicious lesions. The main question the investigators aim to answer is: Can the developed model, using peripheral blood cell-free DNA sequencing, work well in screening and classifying common cancers especially in the early stages? Participants will undergo the collection of 15\~20ml of blood and 1\~2 telephone follow-up calls.
Conditions
- Cancer Diagnosis
- LungCancer
- Gastric Cancer
- Liver Cancer
- Colorectal Cancer
- Esophagus Cancer
- Breast Cancer
- Pancreas Cancer
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2025-08-01
- Completion
- 2025-12-01
- First posted
- 2023-09-14
- Last updated
- 2024-05-16
Locations
8 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06036563. Inclusion in this directory is not an endorsement.